Your browser doesn't support javascript.
loading
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
Sherman, Amy C; Desjardins, Michaël; Cheng, Chi An; Bausk, Bruce; Izaguirre, Natalie; Zhou, Guohai; Krauss, Jonathan; Tolan, Nicole; Walt, David R; Soiffer, Robert; Ho, Vincent T; Issa, Nicolas C; Baden, Lindsey R.
Afiliação
  • Sherman AC; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Desjardins M; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Cheng CA; Harvard Medical School, Boston, Massachusetts, USA.
  • Bausk B; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Izaguirre N; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Zhou G; Division of Infectious Diseases, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Krauss J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Tolan N; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USAand.
  • Walt DR; Harvard Medical School, Boston, Massachusetts, USA.
  • Soiffer R; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Ho VT; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Issa NC; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Baden LR; Brigham and Women's Hospital, Boston, Massachusetts, USA.
Clin Infect Dis ; 75(1): e920-e923, 2022 08 24.
Article em En | MEDLINE | ID: mdl-34726754
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine-induced humoral response and reactogenicity profile are described in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Findings showed that 75.0% (by Simoa assay) or 80.0% (by Roche assay) of the HSCT cohort had a positive antibody response on series completion, compared with 100% in the healthy cohort.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 / Vacinas de mRNA Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 / Vacinas de mRNA Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article